首页> 外文OA文献 >From Lead to Drug Candidate: Optimization of 3(Phenylethynyl)1Hpyrazolo3,4dpyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer

【2h】

From Lead to Drug Candidate: Optimization of 3(Phenylethynyl)1Hpyrazolo3,4dpyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer

机译：从导致药物候选物中：优化3（苯基乙炔基）1HPyrazolo 3,4d嘧啶-4-胺衍生物作为治疗三重阴性乳腺癌的药剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 -1
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. From Lead to Drug Candidate: Optimization of 3-(Phenylethyny1)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer [J] . Zhang Chun-Hui, Chen Kai, Jiao Yan, Journal of Medicinal Chemistry . 2016,第21期

机译：从铅到药物候选者：3-（Phenylethyny1）-1H-吡唑并[3,4-d]嘧啶-4-胺衍生物作为三阴性乳腺癌治疗药物的优化
2. Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer [J] . Zhang Chun-Hui, Zheng Ming-Wu, Li Ya-Ping, Journal of Medicinal Chemistry . 2015,第9期

机译：3-（苯基乙炔基）-1H-吡唑并[3,4-d]嘧啶-4-胺衍生物作为三类阴性乳腺癌模型中具有强活性的新型Src抑制剂的设计，合成及构效关系研究
3. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells [J] . Pracharova Jitka, Novohradsky Vojtech, Kostrhunova Hana, Dalton transactions: An international journal of inorganic chemistry . 2018,第35期

机译：半三明治OS（II）和Ru（II）洗浴盆藻胺配合物：抗癌药物候选人具有异常效力和具有高度侵入性三阴性乳腺癌细胞的细胞活性型材
4. Co-delivery of chemo drug and siRNA using layer-by-layer nanoparticles for triple negative breast cancer treatment [C] . Jason Z. Deng, Stephen Morton, Paula Hammond Society for biomaterials annual meeting and exposition . 2013

机译：使用层状纳米颗粒共同递送化学药物和siRNA用于三阴性乳腺癌的治疗
5. Drug Delivery Strategies for Treatment of Triple Negative Breast Cancer, Ocular Diseases and Biofabrication of Invitro Models [D] . Kutlehria, Shallu. 2020

机译：用于治疗三重阴性乳腺癌，眼部疾病和invitro模型生物制剂的药物递送策略
6. Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions [O] . Jeng-Yuan Shiau, Yong-Qun Chang, Kyoko Nakagawa-Goto, 2017

机译：植物活性剂脱氧elephanphantopin及其衍生物通过ROS介导的外泌体活性和蛋白质功能抑制三阴性乳腺癌细胞活性。
7. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer [O] . J. D. Obayemi, A. A. Salifu, S. C. Eluu, 2020

机译：LHRH-缀合的药物作为靶向治疗剂的特异性靶向和局部治疗三重阴性乳腺癌

From Lead to Drug Candidate: Optimization of 3(Phenylethynyl)1Hpyrazolo3,4dpyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer

著录项

相似文献

相关主题

期刊订阅